Skip to main content
Year archive

Galapagos NV — 2020 filings

All 156 regulatory filings released by Galapagos NV (GLPG) in 2020, sourced directly from the official regulator.

156 Filings
2020 Period
2020 filings (156)
Filing Released Lang
CORRECTIE EN VERVANGING - Galapagos’ CEO doneert €10 miljoen in de vorm van persoonlijke aandelen aan African Parks
Share Issue/Capital Change
2020-12-24 Dutch
Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks
Environmental & Social Information
2020-12-24 English
Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks
Major Shareholding Notification
2020-12-24 English
Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
Regulatory Filings
2020-12-16 Dutch
Gilead and Galapagos announce New Commercialization and Development Agreement for Jyseleca® (filgotinib)
Regulatory Filings
2020-12-16 English
GILEAD AND GALAPAGOS ANNOUNCE NEW COMMERCIALIZATION AND DEVELOPMENT AGREEMENT FOR JYSELECA® (FILGOTINIB)
Regulatory Filings
2020-12-15 English
GILEAD EN GALAPAGOS KONDIGEN NIEUWE COMMERCIALISERING EN ONTWIKKELINGSOVEREENKOMST AAN VOOR JYSELECA® (FILGOTINIB)
Regulatory Filings
2020-12-15 Dutch
6-K Filing
Foreign Filer Report
2020-12-15 English
6-K Filing
Foreign Filer Report
2020-12-07 English
Galapagos increases share capital through subscription right exercises.pdf
Share Issue/Capital Change
2020-12-04 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Share Issue/Capital Change
2020-12-04 Dutch
6-K Filing
Foreign Filer Report
2020-12-03 English
6-K Filing
Foreign Filer Report
2020-11-30 English
Selvita to acquire Fidelta from Galapagos
M&A Activity
2020-11-24 English
Selvita to acquire Fidelta from Galapagos
M&A Activity
2020-11-24 Dutch
6-K Filing
Foreign Filer Report
2020-11-24 English
First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial
Earnings Release Q4 2020
2020-11-10 English
First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial
Earnings Release Q4 2020
2020-11-10 English
6-K Filing
Foreign Filer Report
2020-11-10 English
6-K Filing
Foreign Filer Report
2020-11-09 English
Galapagos reports Q3 2020 results
Interim / Quarterly Report 9M 2020
2020-11-06 English
Galapagos reports Q3 2020 results
Earnings Release 9M 2020
2020-11-06 Dutch
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
Capital/Financing Update
2020-11-06 Dutch
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
Regulatory Filings
2020-11-06 English
6-K Filing
Foreign Filer Report
2020-11-06 English
Galapagos reports Q3 2020 results.pdf
Interim / Quarterly Report 9M 2020
2020-11-05 English
Galapagos rapporteert derde kwartaalresultaten 2020.pdf
Earnings Release 9M 2020
2020-11-05 Dutch
Q3 report 2020.pdf
Interim / Quarterly Report 9M 2020
2020-11-05 English
Q3 verslag 2020.pdf
Interim / Quarterly Report 9M 2020
2020-11-05 Dutch
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF ULCERATIVE COLITIS
Regulatory Filings
2020-11-03 English
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF ULCERATIVE COLITIS
Regulatory Filings
2020-11-03 English
6-K Filing
Foreign Filer Report
2020-11-03 English
Galapagos’ R&D Roundtable showcases Toledo program
Regulatory Filings
2020-10-28 English
Galapagos’ R&D Roundtable showcases Toledo program
Earnings Release FY 2020
2020-10-28 Dutch
6-K Filing
Foreign Filer Report
2020-10-27 English
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
Earnings Release Q4 2020
2020-10-16 Dutch
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
Earnings Release Q4 2020
2020-10-16 English
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972 S201086 in knee osteoarthritis patients
Earnings Release Q4 2020
2020-10-15 English
Galapagos en Servier rapporteren topline resultaten van ROCCELLA fase 2-studie met GLPG1972 S201086 bij patiënten met artrose in de knie
Earnings Release Q4 2020
2020-10-15 Dutch
6-K Filing
Foreign Filer Report
2020-10-15 English
6-K Filing
Foreign Filer Report
2020-10-13 English
PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS
Earnings Release Q2 2020
2020-10-12 English
PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE ULCERATIVE COLITIS
Earnings Release Q3 2020
2020-10-12 Dutch
S-8 Filing
Registration Form
2020-10-09 English
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
Earnings Release Q3 2020
2020-09-30 English
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
Regulatory Filings
2020-09-30 English
6-K Filing
Foreign Filer Report
2020-09-30 English
EUROPESE COMMISSIE VERLEENT HANDELSVERGUNNING VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE REUMATOïDE ARTRITIS
Regulatory Filings
2020-09-28 Dutch
EUROPESE COMMISSIE VERLEENT HANDELSVERGUNNING VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE REUMATOïDE ARTRITIS
Regulatory Filings
2020-09-28 English
6-K Filing
Foreign Filer Report
2020-09-28 English
Correction: Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Regulatory Filings
2020-09-25 English
Correction: Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Regulatory Filings
2020-09-25 English
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Regulatory Filings
2020-09-25 English
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
Regulatory Filings
2020-09-25 English
6-K Filing
Foreign Filer Report
2020-09-25 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2020-09-21 Dutch
Galapagos increases share capital through subscription right exercises
Declaration of Voting Results & Voting Rights Announcements
2020-09-21 English
6-K Filing
Foreign Filer Report
2020-09-21 English
Share Capital Increase - 18 September 2020 - EN.pdf
Share Issue/Capital Change
2020-09-18 English
Share Capital Increase - 18 September 2020 - NL.pdf
Share Issue/Capital Change
2020-09-18 Dutch
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
Earnings Release Q3 2020
2020-09-11 English
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
Earnings Release Q3 2020
2020-09-11 English
6-K Filing
Foreign Filer Report
2020-09-11 English
Galapagos presenteert nieuwe inzichten in IPF en gerelateerde klinische ontwikkelingen op het European Respiratory Society Congress
Investor Presentation
2020-08-26 Dutch
Galapagos presenteert nieuwe inzichten in IPF en gerelateerde klinische ontwikkelingen op het European Respiratory Society Congress
Regulatory Filings
2020-08-26 Dutch
6-K Filing
Foreign Filer Report
2020-08-26 English
Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis
Legal Proceedings Report
2020-08-19 English
Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis
Legal Proceedings Report
2020-08-19 English
6-K Filing
Foreign Filer Report
2020-08-19 English
Galapagos announces that Gilead received a complete response letter for filgotinib for the treatment of moderately to severely active rheumatoid arthritis
Earnings Release FY 2020
2020-08-19 English
Galapagos kondigt aan dat Gilead een Complete Response Letter voor filgotinib heeft ontvangen voor de behandeling van matige tot ernstige actieve reumatoïde artritis
Regulatory Filings
2020-08-19 Dutch
Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease
Regulatory Filings
2020-08-13 Dutch
Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease
Regulatory Filings
2020-08-13 English
6-K Filing
Foreign Filer Report
2020-08-13 English
Galapagos reports solid H1 2020 progress
Earnings Release H1 2020
2020-08-07 English
Galapagos reports solid H1 2020 progress
Earnings Release H1 2020
2020-08-07 Dutch
Galapagos reports solid H1 2020 progress .pdf
Earnings Release H1 2020
2020-08-06 English
Galapagos rapporteert sterke voortgang in H1 2020.pdf
Earnings Release H1 2020
2020-08-06 Dutch
H1 report 2020.pdf
Interim / Quarterly Report H1 2020
2020-08-06 English
Halfjaarverslag 2020.pdf
Interim / Quarterly Report H1 2020
2020-08-06 Dutch
6-K Filing
Foreign Filer Report
2020-08-06 English
GILEAD AND GALAPAGOS ANNOUNCE POSITIVE EUROPEAN CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Earnings Release Q2 2020
2020-07-24 English
GILEAD AND GALAPAGOS ANNOUNCE POSITIVE EUROPEAN CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Legal Proceedings Report
2020-07-24 English
GILEAD AND GALAPAGOS ANNOUNCE POSITIVE EUROPEAN CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Regulatory Filings
2020-07-24 English
GILEAD EN GALAPAGOS KONDIGEN POSITIEVE EUROPESE CHMP OPINIE AAN VOOR JYSELECA® (FILGOTINIB) VOOR DE BEHANDELING VAN VOLWASSENEN MET MATIGE TOT ERNSTIGE REUMATOïDE ARTRITIS
Regulatory Filings
2020-07-24 Dutch
6-K Filing
Foreign Filer Report
2020-07-24 English
NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS
Earnings Release Q1 2020
2020-06-08 Dutch
NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS
Earnings Release Q1 2020
2020-06-08 English
6-K Filing
Foreign Filer Report
2020-06-08 English
FILGOTINIB DEMONSTRATES DURABLE EFFICACY AND CONSISTENT SAFETY PROFILE AT 52 WEEKS IN FINCH 1 AND 3 STUDIES IN RHEUMATOID ARTHRITIS
Earnings Release Q1 2020
2020-06-04 English
FILGOTINIB DEMONSTRATES DURABLE EFFICACY AND CONSISTENT SAFETY PROFILE AT 52 WEEKS IN FINCH 1 AND 3 STUDIES IN RHEUMATOID ARTHRITIS
Earnings Release Q2 2020
2020-06-04 English
6-K Filing
Foreign Filer Report
2020-06-04 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2020-05-29 Dutch
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2020-05-29 English
6-K Filing
Foreign Filer Report
2020-05-29 English
Share Capital Increase - 28 May 2020 - EN.pdf
Share Issue/Capital Change
2020-05-28 English
Share Capital Increase - 28 May 2020 - NL.pdf
Share Issue/Capital Change
2020-05-28 Dutch
6-K Filing
Foreign Filer Report
2020-05-26 English
GILEAD AND GALAPAGOS ANNOUNCE POSITIVE TOPLINE RESULTS OF PHASE 2B/3 TRIAL OF FILGOTINIB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Regulatory Filings
2020-05-21 English
GILEAD AND GALAPAGOS ANNOUNCE POSITIVE TOPLINE RESULTS OF PHASE 2B/3 TRIAL OF FILGOTINIB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Earnings Release Q2 2020
2020-05-21 English
GILEAD AND GALAPAGOS ANNOUNCE POSITIVE TOPLINE RESULTS OF PHASE 2B/3 TRIAL OF FILGOTINIB IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Earnings Release Q2 2020
2020-05-20 English
GILEAD EN GALAPAGOS KONDIGEN POSITIEVE RESULTATEN AAN VAN FASE 2B/3-STUDIE MET FILGOTINIB VOOR DE BEHANDELING VAN MATIGE TOT ERNSTIGE COLITIS ULCEROSA
Regulatory Filings
2020-05-20 Dutch
6-K Filing
Foreign Filer Report
2020-05-11 English
On track for clinical read-outs and commercial readiness in 2020
Earnings Release Q1 2020
2020-05-08 English
On track for clinical read-outs and commercial readiness in 2020
Earnings Release Q1 2020
2020-05-08 Dutch
PR Q1 2020 FINAL.pdf
Interim / Quarterly Report Q1 2020
2020-05-07 English
PR Q1 2020 FINAL NL.pdf
Interim / Quarterly Report Q1 2020
2020-05-07 Dutch
Q1 2020 FINAL report.pdf
Interim / Quarterly Report Q1 2020
2020-05-07 English
Q1 2020 NL FINAL report.pdf
Interim / Quarterly Report Q1 2020
2020-05-07 Dutch
6-K Filing
Foreign Filer Report
2020-04-29 English
Minutes 28 April 2020.pdf
AGM Information
2020-04-28 English
Notulen 28 April 2020.pdf
AGM Information
2020-04-28 Dutch
Galapagos creates new subscription right plans
Remuneration Information
2020-04-20 English
Galapagos creates new subscription right plans
Remuneration Information
2020-04-20 Dutch
eCorporate documenten_final.pdf
Report Publication Announcement
2020-04-17 Dutch
AR Galapagos NV - Issuance of subscription rights and cancellation statutory preferential subscr rig.pdf
Audit Report / Information FY 2020
2020-04-17 English
AR Galapagos NV - Uitgifte inschrijvingsrechten met opheffing van het voorkeurrecht (17.04.2020-NL)(.pdf
Audit Report / Information FY 2020
2020-04-17 Dutch
Subscription Right Plan 2020_BoD Report_7_180-7_191_E_website.pdf
Share Issue/Capital Change
2020-04-17 English
Subscription Right Plan 2020_BoD Report_7_180-7_191_D_for website.pdf
Capital/Financing Update
2020-04-17 Dutch
Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetings
AGM Information
2020-04-17 English
Important update to Galapagos’ invitation to its ordinary and extraordinary shareholders’ meetings
AGM Information
2020-04-17 Dutch
6-K Filing
Foreign Filer Report
2020-04-17 English
6-K Filing
Foreign Filer Report
2020-04-17 English
6-K Filing
Foreign Filer Report
2020-04-16 English
Publication of the annual report and invitation to the ordinary and extraordinary shareholders’ meetings
AGM Information
2020-03-30 Dutch
Publication of the annual report and invitation to the ordinary and extraordinary shareholders’ meetings
AGM Information
2020-03-30 English
Annual Report 2019_final_English.pdf
Annual Report FY 2019
2020-03-27 English
Annual Report 2019_final_Nederlands.pdf
Annual Report FY 2019
2020-03-27 Dutch
20-F Filing
Annual Report FY 2019
2020-03-27 English
6-K Filing
Foreign Filer Report
2020-03-27 English
Galapagos increases share capital through warrant exercises
Capital/Financing Update
2020-03-18 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2020-03-18 English
Share Capital Increase - 17 March 2020 - EN.pdf
Share Issue/Capital Change
2020-03-17 English
Share Capital Increase - 17 March 2020 - NL.pdf
Capital/Financing Update
2020-03-17 Dutch
6-K Filing
Foreign Filer Report
2020-03-17 English
Transformational year for Galapagos
Earnings Release FY 2019
2020-02-21 Dutch
SC 13G/A Filing
Major Shareholding Notification
2020-02-14 English
SC 13G/A Filing
Major Shareholding Notification
2020-02-14 English
Orphan Drug Designation for GLPG1690 in systemic sclerosis
Regulatory Filings
2020-01-29 Dutch
Orphan Drug Designation for GLPG1690 in systemic sclerosis
Earnings Release Q1 2020
2020-01-29 English
6-K Filing
Foreign Filer Report
2020-01-29 English
SC 13G/A Filing
Major Shareholding Notification
2020-01-27 English
Galapagos appoints Michele Manto as Chief Commercial Officer
Board/Management Information
2020-01-24 Dutch
6-K Filing
Foreign Filer Report
2020-01-24 English
Fibrocor and Galapagos sign expanded collaboration in fibrosis
Capital/Financing Update
2020-01-15 Dutch
Fibrocor and Galapagos sign expanded collaboration in fibrosis
Regulatory Filings
2020-01-15 English
6-K Filing
Foreign Filer Report
2020-01-15 English
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis
Regulatory Filings
2020-01-13 Dutch
Galapagos completes recruitment of PINTA trial in idiopathic pulmonary fibrosis
Regulatory Filings
2020-01-13 English
6-K Filing
Foreign Filer Report
2020-01-13 English
Galapagos to present at 38th Annual J.P. Morgan Healthcare Conference
AGM Information
2020-01-10 English
Gilead holds 25.84% of Galapagos shares
Major Shareholding Notification
2020-01-10 English
6-K Filing
Foreign Filer Report
2020-01-10 English
6-K Filing
Foreign Filer Report
2020-01-10 English
Transparency PR Gilead_FINAL.pdf
Major Shareholding Notification
2020-01-09 English
Tranparency Gilead PR (NL) FINAL.pdf
Major Shareholding Notification
2020-01-09 Dutch